Breast Cancer Prevention and Treatment
Autor Lida A. Mina, Anna Maria Storniolo, Hal Douglas Kipfer, Cindy Hunter, Kandice K. Ludwigen Limba Engleză Paperback – 13 iun 2016
· Who is at elevated risk for breast cancer?
· Who should be genetically screened?
· When and how often should we obtain imaging?
· What type of imaging is adequate?
· What medications are available for prevention?
· When is surgical intervention appropriate?
· What lifestyle changes should be implemented to prevent thisdisaster?
With one in eight women likely to contract breast cancer in herlifetime, the significance of identifying and managing the high-risk patient isevident. Breakthroughs in the identification of genes associated with breastcarcinoma, particularly BRCA1 and 2,as well as other risk factors, influence not only how patients are screened,but also how they are treated. Breast Cancer Prevention and Treatment providesa guided approach to prevention of breast cancer in women at elevated risk forthis malignancy.
Preț: 362.88 lei
Preț vechi: 381.98 lei
-5% Nou
Puncte Express: 544
Preț estimativ în valută:
69.45€ • 71.89$ • 58.70£
69.45€ • 71.89$ • 58.70£
Carte disponibilă
Livrare economică 13-27 februarie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783319194363
ISBN-10: 3319194364
Pagini: 150
Ilustrații: VII, 104 p. 12 illus., 7 illus. in color.
Dimensiuni: 155 x 235 x 11 mm
Greutate: 0.27 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3319194364
Pagini: 150
Ilustrații: VII, 104 p. 12 illus., 7 illus. in color.
Dimensiuni: 155 x 235 x 11 mm
Greutate: 0.27 kg
Ediția:1st ed. 2016
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Public țintă
Professional/practitionerCuprins
1. Introduction to breast cancer: The Magnitude of the problem.- 2. Risk Factors for Breast Cancer.- 3. Defining the population at elevated risk for Breast Cancer: Risk Models.- 4. Genetic predisposition and Genetic screening.- 5. The BRCA patient population.- 6. Women with benign proliferative breast disease.- 7. Approach to Imaging.- 8. Chemoprevention.- 9. Lifestyle and Breast Cancer.- 10. Obesity and Inflammation.- 11. Conclusion/the Future/ Komen Tissue Bank/Clinical Trials.
Notă biografică
Dr. Lida Mina received her MD from the American University ofBeirut. She is a medical oncologist and Assistant Professor of ClinicalMedicine at the Indiana University School of Medicine. Dr. Mina treats patientswith breast cancer as well as patients at an elevated risk of developing thedisease. She is the director of the Catherine Peachy Breast Cancer PreventionProgram at the Indiana University Health Simon Cancer Center.
Dr. Anna Maria Storniolo received her MD from Stanford University. She is a medical oncologist and Professor of Clinical Medicine at theIndiana University School of Medicine. In addition to caring for patientswith all stages of breast cancer, she also sees women at elevated risk of thedisease. She is the founder and executive director of the Susan G. KomenTissue Bank at the IU Simon Cancer Center, the world’s only repository ofnormal breast tissue.
Cindy Hunter, MS, CGC is a licensed, certified genetic counselorwho has worked in the field of cancer genetic counseling since 1996. Cindy isone of the pillars of the Catherine Peachy Breast Cancer Prevention Program atthe Indiana University Health Simon Cancer Center.
Dr. Kandice Ludwig received her medical degree from LouisianaState University School of Medicine. She is a practicing breast surgeon atIndiana University School of Medicine, and has been appointed AssistantProfessor of Clinical Surgery. Her clinical interests include younger womenwith breast cancer, and management of women with high risk pathology.
Dr. Hal Kipfer received his Medical Degree at the IndianaUniversity School of Medicine. He spent the past 10 years in a dedicated breastimaging and intervention practice with special interest in resident and felloweducation, as well as breast MRI protocol development. He believes faster andshorter MRI sequences can improve value, and allow more women to benefit from screening breast MRI.
Dr. Anna Maria Storniolo received her MD from Stanford University. She is a medical oncologist and Professor of Clinical Medicine at theIndiana University School of Medicine. In addition to caring for patientswith all stages of breast cancer, she also sees women at elevated risk of thedisease. She is the founder and executive director of the Susan G. KomenTissue Bank at the IU Simon Cancer Center, the world’s only repository ofnormal breast tissue.
Cindy Hunter, MS, CGC is a licensed, certified genetic counselorwho has worked in the field of cancer genetic counseling since 1996. Cindy isone of the pillars of the Catherine Peachy Breast Cancer Prevention Program atthe Indiana University Health Simon Cancer Center.
Dr. Kandice Ludwig received her medical degree from LouisianaState University School of Medicine. She is a practicing breast surgeon atIndiana University School of Medicine, and has been appointed AssistantProfessor of Clinical Surgery. Her clinical interests include younger womenwith breast cancer, and management of women with high risk pathology.
Dr. Hal Kipfer received his Medical Degree at the IndianaUniversity School of Medicine. He spent the past 10 years in a dedicated breastimaging and intervention practice with special interest in resident and felloweducation, as well as breast MRI protocol development. He believes faster andshorter MRI sequences can improve value, and allow more women to benefit from screening breast MRI.
Textul de pe ultima copertă
Uniquelydesigned for oncologists and general practitioners, this book offers clinicianscomprehensive guidelines when dealing with women at high risk for breastcancer. Written by experts in the field on the cutting edge of this research,the following questions will be answered for the reader by the end of the book:
· Who is at elevated risk for breast cancer?
· Who should be genetically screened?
· When and how often should we obtain imaging?
· What type of imaging is adequate?
· What medications are available for prevention?
· When is surgical intervention appropriate?
· What lifestyle changes should be implemented to prevent thisdisaster?
With one in eight women likely to contract breast cancer in herlifetime, the significance of identifying and managing the high-risk patient isevident. Breakthroughs in the identification of genes associated with breastcarcinoma, particularly BRCA1 and 2,as well as other risk factors, influence not only how patients are screened,but also how they are treated. Breast Cancer Prevention and Treatment providesa guided approach to prevention of breast cancer in women at elevated risk forthis malignancy.
· Who is at elevated risk for breast cancer?
· Who should be genetically screened?
· When and how often should we obtain imaging?
· What type of imaging is adequate?
· What medications are available for prevention?
· When is surgical intervention appropriate?
· What lifestyle changes should be implemented to prevent thisdisaster?
With one in eight women likely to contract breast cancer in herlifetime, the significance of identifying and managing the high-risk patient isevident. Breakthroughs in the identification of genes associated with breastcarcinoma, particularly BRCA1 and 2,as well as other risk factors, influence not only how patients are screened,but also how they are treated. Breast Cancer Prevention and Treatment providesa guided approach to prevention of breast cancer in women at elevated risk forthis malignancy.
Caracteristici
Provides a guided approach to prevention of breast cancer in women at elevated risk for this malignancy Unique in offering oncologists and general practitioners comprehensive guidelines when dealing with women at high risk for breast cancer Answers questions such as who is at elevated risk, who should be genetically screened and what lifestyle changes should be implemented to prevent the disease